Executive SummaryFirm says sale of its U.S. animal health div. to Solvay will result in after tax gain of approximately $12 mil. Squibb says divestiture "conforms with the company's strategic plan to focus on product areas where we can attain competitive advantage through basic research." The firm's animal health business outside the U.S. will not be affected.
You may also be interested in...
Updated medtech notified body figures from the European Commission always make headline news. But industry needs to see real appointments now, not a list of tricky-to-understand numbers.
Full, planned acquisition of Tokyo-based operation will give US biotech giant a firmer foothold in key market and new platform for Otezla growth.
Quanta Dialysis is linking up with B. Braun Avitum UK to support patients with Quanta’s personal hemodialysis device in the home. See what Quanta CEO John Milad said about it here.